Perspective Therapeutics (CATX) EBITDA (2010 - 2026)
Perspective Therapeutics (CATX) posted EBITDA of -$28.3 million for Q1 2026, down 100.88% sequentially from $3.2 billion in Q4 2025, and down 29.54% YoY from -$40.1 million in Q1 2025.
Perspective Therapeutics (CATX) EBITDA (2010 - 2026) Analysis & Trends
Perspective Therapeutics has reported EBITDA for 17 years, with the latest figure at -$28.3 million in Q1 2026.
- Quarterly EBITDA fell 29.54% year-over-year to -$28.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 billion (up 3263.51% YoY) and the FY2025 annual result came in at -$113.6 million, down 24.95% from the prior year.
- EBITDA retreated to -$28.3 million in Q1 2026 per CATX's latest filing, from $3.2 billion in the prior quarter.
- Over five years, EBITDA peaked at $3.2 billion in Q4 2025 and troughed at -$45.0 million in Q4 2024.
- A 5-year average of $175.4 million and a median of -$11.7 million in 2023 frame the typical range for EBITDA.
- The sharpest annual moves came in 2023 and 2025: EBITDA tumbled 609.38% in 2023, then surged 7272.93% in 2025.
- Over 5 years, EBITDA stood at -$5.6 million in 2022, then plunged by 107.72% to -$11.7 million in 2023, then plunged by 285.27% to -$45.0 million in 2024, then soared by 7272.93% to $3.2 billion in 2025, then slumped by 100.88% to -$28.3 million in 2026.
- According to Business Quant data, EBITDA over the past three periods registered -$28.3 million, $3.2 billion, and -$24.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Perspective Therapeutics | 387.89 Mn | 387.89 Mn | - | -29.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.26 Mn |
| Mar 31, 2026 | -28.28 Mn |
| Dec 31, 2025 | 3.23 Bn |
| Sep 30, 2025 | -24.11 Mn |
| Jun 30, 2025 | -19.86 Mn |
| Mar 31, 2025 | -21.83 Mn |
| Dec 31, 2024 | -44.98 Mn |
| Sep 30, 2024 | -18.63 Mn |
| Jun 30, 2024 | -14.26 Mn |
| Mar 31, 2024 | -13.01 Mn |
| Dec 31, 2023 | -11.68 Mn |
| Sep 30, 2023 | -9.75 Mn |
| Jun 30, 2023 | -9.75 Mn |
| Mar 31, 2023 | -9.76 Mn |
| Dec 31, 2022 | -5.62 Mn |
| Sep 30, 2022 | -7.69 Mn |
| Jun 30, 2022 | -3.48 Mn |
| Mar 31, 2022 | -1.38 Mn |
| Dec 31, 2021 | -1.64 Mn |
| Sep 30, 2021 | -2.27 Mn |